Deuterated Drugs Market: By Type (Austedo, Zepsun Others) Application (Huntington’s Disease (HD), Tardive Dyskinesia (TD), Cancer Others) and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

1. Executive Summary
2. Deuterated Drugs Market Introduction
2.1. Global Deuterated Drugs Market – Taxonomy
2.2. Global Deuterated Drugs Market –Definitions
2.2.1. By Type
2.2.2. By Application
2.2.3. By Region
3. Global Deuterated Drugs Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Deuterated Drugs Market Dynamic Factors - Impact Analysis
3.6. Global Deuterated Drugs Market – Competition Landscape
4. Global Deuterated Drugs Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028
4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Deuterated Drugs Market, By Type, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
5.1. Austedo
5.1.1.  Market Analysis, 2017-2021  and Forecast, 2022 -2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Zepsun
5.2.1. Market Analysis, 2017-2021  and Forecast, 2022 -2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Others
5.3.1. Market Analysis, 2017-2021  and Forecast, 2022 -2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Deuterated Drugs Market, By Application, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
6.1. Huntington’s Disease (HD)
6.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Tardive Dyskinesia (TD)
6.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Cancer
6.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Others
6.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. Global Deuterated Drugs Market Forecast, By Region, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
7.1. North America
7.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Deuterated Drugs Market - Opportunity Analysis Index, By Type, By Application and Region, 2022 - 2028
8. North America Deuterated Drugs Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
8.1. Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.1.1. Austedo
8.1.2. Zepsun
8.1.3. Others
8.2. Application Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.2.1. Huntington’s Disease (HD)
8.2.2. Tardive Dyskinesia (TD)
8.2.3. Cancer
8.2.4. Others
8.3. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
8.3.1. USA
8.3.2. Canada
8.4. North America Deuterated Drugs Market - Opportunity Analysis Index, By Type, By Application and Country, 2022 - 2028
8.5. North America Deuterated Drugs Market Dynamics – Trends
9. Europe Deuterated Drugs Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
9.1. Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Austedo
9.1.2. Zepsun
9.1.3. Others
9.2. Application Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.2.1. Huntington’s Disease (HD)
9.2.2. Tardive Dyskinesia (TD)
9.2.3. Cancer
9.2.4. Others
9.3. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Russia
9.3.7. Rest of Europe
9.4. Europe Deuterated Drugs Market - Opportunity Analysis Index, By Type, By Application and Country, 2022 - 2028
9.5. Europe Deuterated Drugs Market Dynamics – Trends
10. Asia-Pacific Deuterated Drugs Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
10.1. Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Austedo
10.1.2. Zepsun
10.1.3. Others
10.2. Application Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Huntington’s Disease (HD)
10.2.2. Tardive Dyskinesia (TD)
10.2.3. Cancer
10.2.4. Others
10.3. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. ASEAN
10.3.5. Australia & New Zealand
10.3.6. Rest of Asia-Pacific
10.4. Asia-Pacific Deuterated Drugs Market - Opportunity Analysis Index, By Type, By Application, and Country, 2022 - 2028
10.5. Asia-Pacific Deuterated Drugs Market Dynamics – Trends
11. Latin America Deuterated Drugs Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
11.1. Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Austedo
11.1.2. Zepsun
11.1.3. Others
11.2. Application Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Huntington’s Disease (HD)
11.2.2. Tardive Dyskinesia (TD)
11.2.3. Cancer
11.2.4. Others
11.3. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Argentina
11.3.4. Rest of Latin America
11.4. Latin America Deuterated Drugs Market - Opportunity Analysis Index, By Type, By Application and Country, 2022 - 2028
11.5. Latin America Deuterated Drugs Market Dynamics – Trends
12. Middle East and Africa Deuterated Drugs Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
12.1. Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Austedo
12.1.2. Zepsun
12.1.3. Others
12.2. Application Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Huntington’s Disease (HD)
12.2.2. Tardive Dyskinesia (TD)
12.2.3. Cancer
12.2.4. Others
12.3. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.3.1. Gulf Cooperation Council (GCC) Countries
12.3.2. Israel
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA Deuterated Drugs Market - Opportunity Analysis Index, By Type, By Application and Country, 2022 - 2028
12.5. MEA Deuterated Drugs Market Dynamics – Trends
13. Competition Landscape
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. Teva
13.2.2. Suzhou Zelgen Biopharmaceuticals
13.2.3. Concert Pharmaceuticals
13.2.4. Vertex Pharmaceuticals
13.2.5. Hinova Pharma
13.2.6. Otsuka Pharmaceutical (Avanir)
13.2.7. Poxel SA (DeuteRx)
14. Research Methodology
15. Key Assumptions and Acronyms

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • Teva
  • Suzhou Zelgen Biopharmaceuticals
  • Concert Pharmaceuticals
  • Vertex Pharmaceuticals
  • Hinova Pharma
  • Otsuka Pharmaceutical (Avanir)
  • Poxel SA (DeuteRx)

Adjacent Markets